Almost all COVID-19 patients in our study produced and maintained high titers of nAbs (Figure 1a) and mounted a high level of IgG and IgM antibodies to SARS-CoV-2 S1 (Figure 1b) and N proteins (Figure 1c) despite their disease severity (Figure S1). This evidence concerns the gene CD40LG and COVID-19.